Literature DB >> 26093511

Breast cancer screening controversies: who, when, why, and how?

Alison Chetlen1, Julie Mack2, Tiffany Chan3.   

Abstract

Mammographic screening is effective in reducing mortality from breast cancer. The issue is not whether mammography is effective, but whether the false positive rate and false negative rates can be reduced. This review will discuss controversies including the reduction in breast cancer mortality, overdiagnosis, the ideal screening candidate, and the optimal imaging modality for breast cancer screening. The article will compare and contrast screening mammography, tomosynthesis, whole-breast screening ultrasound, magnetic resonance imaging, and molecular breast imaging. Though supplemental imaging modalities are being utilized to improve breast cancer diagnosis, mammography still remains the gold standard for breast cancer screening.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Automated whole-breast ultrasound; Breast cancer screening; Magnetic resonance imaging; Mammography; Tomosynthesis

Mesh:

Year:  2015        PMID: 26093511     DOI: 10.1016/j.clinimag.2015.05.017

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  15 in total

Review 1.  Applications of Advanced Breast Imaging Modalities.

Authors:  Arwa A Alzaghal; Pamela J DiPiro
Journal:  Curr Oncol Rep       Date:  2018-05-29       Impact factor: 5.075

2.  Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies.

Authors:  Nikolai Mühlberger; Gaby Sroczynski; Artemisa Gogollari; Beate Jahn; Nora Pashayan; Ewout Steyerberg; Martin Widschwendter; Uwe Siebert
Journal:  Eur J Health Econ       Date:  2021-08-03

3.  Estimating the costs and cost-effectiveness of promoting mammography screening among US-based Latinas.

Authors:  Yamilé Molina; Catherine M Pichardo; Donald L Patrick; Scott D Ramsey; Sonia Bishop; Shirley A A Beresford; Gloria D Coronado
Journal:  J Health Dispar Res Pract       Date:  2018

4.  Role of short-term follow-up magnetic resonance imaging in the detection of post-operative residual breast cancer.

Authors:  Yili Zhang; Hongwen Du
Journal:  Mol Clin Oncol       Date:  2016-06-09

5.  Associated factors with mammographic changes in women undergoing breast cancer screening.

Authors:  Ricardo Soares de Sant'Ana; Jacó Saraiva de Castro Mattos; Anderson Soares da Silva; Luanes Marques de Mello; Altacílio Aparecido Nunes
Journal:  Einstein (Sao Paulo)       Date:  2016 Jul-Sep

6.  A meta-analysis: Is there any association between MiR-608 rs4919510 polymorphism and breast cancer risks?

Authors:  Jing Wang; Xiangyi Kong; Zeyu Xing; Xiangyu Wang; Jie Zhai; Yi Fang; Jidong Gao
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

7.  Frequencies of Private Mentions and Sharing of Mammography and Breast Cancer Terms on Facebook: A Pilot Study.

Authors:  Marco Huesch; Alison Chetlen; Joel Segel; Susann Schetter
Journal:  J Med Internet Res       Date:  2017-06-09       Impact factor: 5.428

8.  The P.I.N.K. Study Approach for Supporting Personalized Risk Assessment and Early Diagnosis of Breast Cancer.

Authors:  Michela Franchini; Stefania Pieroni; Edgardo Montrucchio; Jacopo Nori Cucchiari; Cosimo Di Maggio; Enrico Cassano; Brunella Di Nubila; Gian Marco Giuseppetti; Alberto Nicolucci; Gianfranco Scaperrotta; Paolo Belli; Sonia Santicchia; Sabrina Molinaro
Journal:  Int J Environ Res Public Health       Date:  2021-03-02       Impact factor: 3.390

9.  Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors.

Authors:  Laura Jeffords Moore; Lopamudra Das Roy; Ru Zhou; Priyanka Grover; Shu-Ta Wu; Jennifer M Curry; Lloye M Dillon; Priya M Puri; Mahboubeh Yazdanifar; Rahul Puri; Pinku Mukherjee; Didier Dréau
Journal:  Transl Oncol       Date:  2016-08       Impact factor: 4.243

10.  Modes of Early Detection of Breast Cancer in Katowice Region, Poland.

Authors:  Jan Eugeniusz Zejda; Angelina Kaleta
Journal:  Int J Environ Res Public Health       Date:  2020-04-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.